Fonte: Basic & Clinical Pharmacology & Toxicology. Unidades: FMRP, FCFRP
Assuntos: FARMACOLOGIA, VENENOS DE ORIGEM ANIMAL, BIOTECNOLOGIA
ABNT
DIOGO, Luciana C. et al. Inhibition of snake venoms and phospholipases 'A IND.2' by extracts from native and genetically modified eclipta alba: isolation of active coumestans. Basic & Clinical Pharmacology & Toxicology, v. 104, n. 4, p. 293-299, 2009Tradução . . Acesso em: 11 nov. 2024.APA
Diogo, L. C., Fernandes, R. S., Marcussi, S., Menaldo, D. L., Roberto, P. G., Matrangulo, P. V. F., et al. (2009). Inhibition of snake venoms and phospholipases 'A IND.2' by extracts from native and genetically modified eclipta alba: isolation of active coumestans. Basic & Clinical Pharmacology & Toxicology, 104( 4), 293-299.NLM
Diogo LC, Fernandes RS, Marcussi S, Menaldo DL, Roberto PG, Matrangulo PVF, Pereira PS, França SC, Giuliatti S, Soares AM, Lourenço MV. Inhibition of snake venoms and phospholipases 'A IND.2' by extracts from native and genetically modified eclipta alba: isolation of active coumestans. Basic & Clinical Pharmacology & Toxicology. 2009 ; 104( 4): 293-299.[citado 2024 nov. 11 ]Vancouver
Diogo LC, Fernandes RS, Marcussi S, Menaldo DL, Roberto PG, Matrangulo PVF, Pereira PS, França SC, Giuliatti S, Soares AM, Lourenço MV. Inhibition of snake venoms and phospholipases 'A IND.2' by extracts from native and genetically modified eclipta alba: isolation of active coumestans. Basic & Clinical Pharmacology & Toxicology. 2009 ; 104( 4): 293-299.[citado 2024 nov. 11 ]